Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2019 Oct;187(1):e8-e11.
doi: 10.1111/bjh.16123. Epub 2019 Jul 31.

Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience

Idanna Innocenti  1 , Francesca Morelli  2 , Francesco Autore  1 , Alfonso Piciocchi  3 , Annamaria Frustaci  4 , Francesca R Mauro  5 , Luana Schiattone  6 , Livio Trentin  7 , Giovanni Del Poeta  8 , Gianluigi Reda  9 , Gian M Rigolin  10 , Adalberto Ibatici  11 , Stefania Ciolli  12 , Marta Coscia  13 , Paolo Sportoletti  14 , Roberta Murru  15 , Luciano Levato  16 , Massimo Gentile  17 , Giovanni D'Arena  18 , Dimitar G Efremov  19 , Alessandra Tedeschi  4 , Lydia Scarfò  6 , Antonio Cuneo  10 , Robin Foà  5 , Luca Laurenti  1   2
Affiliations
Multicenter Study

Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience

Idanna Innocenti et al. Br J Haematol. 2019 Oct.
No abstract available

Keywords: B-Cell receptor; chronic lymphocytic leukaemia; ibrutinib; idelalisib; venetoclax.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources